Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

Medicare's new GLP-1 Bridge program offers weight-loss drugs for $50 a month, but the copay sidesteps Part D's cap and Extra ...

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

Some adults in the Coachella Valley may qualify for GLP-1 weight loss drugs through a recently launched Medicare program. Medicare launched a temporary GLP-1 Bridge Program on July 1, which allows ...

The drugs covered under the program include Wegovy tablets and injections, Zepbound KwikPens, and Foundayo tablets ...

A look at what the Medicare GLP-1 Bridge Program covers, what it doesn't, and what plan sponsors need to know.

Starting July 1, about 14 million people on Medicare who have been diagnosed as obese or overweight will be eligible for $50 GLP-1 drugs, ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

Add Yahoo as a preferred source to see more of our stories on Google. Participants in the Medicare GLP-1 Bridge program will be able to receive a GLP-1 — Foundayo, Zepbound or Wegovy (above) — at a ...